DiscoverRadio Advisory
Radio Advisory
Claim Ownership

Radio Advisory

Author: Advisory Board

Subscribed: 46,326Played: 140,144
Share

Description

Radio Advisory is your weekly download on how to untangle healthcare's most pressing challenges, powered by 40 years of Advisory Board research.
Whether it's workforce shortages, industry disruptors, or health equity strategy, we're here to help. Our hosts and seasoned researchers talk with industry experts to equip you with knowledge to confront today’s unanswered questions in healthcare. New episodes drop every Tuesday. | www.advisory.com
215 Episodes
Reverse
Last week, in part two of our series on value-based care, we talked about how CenterWell, Humana’s provider arm, turned to senior-focused primary care to grow their value-based strategy. But as the Medicare Advantage market gets larger, older, and sicker, it is becoming clear that a focus on primary care isn’t enough. The fact is, VBC in specialty care is the future. In part three of our value series, host Rachel (Rae) Woods invites TJ Ackerman, Senior Vice President of Provider and Network Performance at Zing Health, to discuss what good specialty care in Medicare Advantage looks like. We also talk with one of Zing’s provider partners, Will Stokes, Chief Strategy Officer at Strive Health, a leader in value-based kidney care. Together, TJ and Will discuss the importance of payer-provider partners in value-based specialty care. Links: Zing Health offers Medicare Advantage Plans in Illinois, Indiana, and Michigan. (myzinghealth.com) Transforming Kidney Care - Strive Health Register for the “Raising the Value Bar Summit” Ep. 202: Value series: Why CenterWell (and Humana) is going all in on senior care Ep. 201: Value series: What does health system VBC adoption actually look like? Use the Market Scenario Planner Learn about Advisory Board On-Demand Courses Register for the Raising the Value Bar Summit 3 strategies for facing the 'tripledemic' of respiratory viruses A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
Last week, in part one of our series on value-based care, we talked all about health systems taking on risk, and why that looks a bit different for everyone. This week, we're exploring an organization that embodies that principle. CenterWell, Humana's provider arm, is pursuing value-based care by going all in on senior focused care. So how are they doing it? In part two of our value series, host Rachel (Rae) Woods invites CenterWell President, Dr. Sanjay Shetty, to discuss the philosophy behind and strategies for pursuing value-based care through senior care management. Throughout the conversation, they discuss why this strategy is right for CenterWell, what it takes to succeed, and how they are navigating today's market challenges. Links: CenterWell | Reimagining Senior Healthcare Register for the "Raising the Value Bar Summit Ep. 201: Value series: What does health system VBC adoption actually look like? 5 insights from VBC leaders 3 strategies for facing the 'tripledemic' of respiratory viruses How CoxHealth grew their Inspire program to meet surging demand Learn about Advisory Board Fellowship A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
In a few weeks, Advisory Board will be convening leaders across the industry in New Orleans, Louisiana to talk about the meaning of "value" in healthcare. In anticipation of the Value Summit, Radio Advisory will be spending the next three weeks talking about one major expression of value in the industry – value-based care. In the first episode of our mini-series, host Abby Burns invites Advisory Board value-based care experts Clare Wirth and Daniel Kuzmanovich to paint the landscape of health system VBC adoption and break down why the road to VBC is neither linear, nor uniform. Links: Register for the "Raising the Value Bar Summit" VBC self-assessment: Find out where your organization stands 5 insights from VBC leaders Introduction to the series: Envisioning paths to nationwide VBC Ep. 178: What the industry is (still) getting wrong about value-based care Learn more about On-Demand Courses How St. Cloud ENT partnered with an ASC to improve sleep apnea outcomes and grow surgical services A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
In the last five years, the health care industry has seen an explosion of corporate ownership over medical groups. It's been relatively smooth sailing for many of these groups so far—but in 2024, they may face the same challenges as incumbents. In this episode, host Rachel (Rae) Woods invites Advisory Board physician experts Sarah Roller and Eliza Dailey to discuss why 2024 will be a make-or-break year for corporate medical groups, and what that means for the rest of the industry. Links: Bold predictions for healthcare in 2024 What you need to know about rising medical group consolidation Physician employment is changing. What does that mean for the industry? Ep. 198: PE firm General Catalyst is buying a hospital — here's our take Use Advisory Board's Clinician Supply Profiler to see how physician supply in your market compares to others. Register for Advisory Board's Clinical Innovation Summit and learn about sponsorship opportunities. Learn more about Advisory Board Fellowship. A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
Producers' note: We know a lot of organizations have been and are being affected by the major cyberattack of Change Healthcare systems and resulting outages. We won't be addressing it in this episode, but if you have questions or are looking for more information please go to https://www.unitedhealthgroup.com/changehealthcarecyberresponse. The relationship between health plans and providers has always included an element of friction, but lately, it seems like the temperature is rising. And you've probably noticed – public contracting disputes increased by 69% between 2022 and 2023. That's why, in this episode, host Abby Burns invites Advisory Board experts Max Hakanson and Eileen Fennell to discuss why the state of affairs seems to be getting worse, how key flashpoints are fanning the flames, and what each stakeholder says they need to see from their partners in order to mend the relationship. Plus, Advisory Board digital health expert Ty Aderhold makes a cameo appearance to help answer the question: Is AI the solution here? Links: 7 things we want to fix in 2024 (and how to get there) A new era of payer-provider relationships The new era of provider enablement AI in healthcare: Insights from 10 C-suite executives 2024 Raising the Value Bar Summit A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
Corporate entities like health plans, retail companies, and PE firms have aggregated large, diverse portfolios of care delivery assets over the past decade – with one notable exception: no one was buying hospitals. But in January, venture capital firm General Catalyst bucked that trend and announced its intent to acquire Summa Health, a 3-hospital health system in northeastern Ohio. What are they thinking? And what could this mean for the industry? In this episode, host Rachel (Rae) Woods and co-host Abby Burns invite Advisory Board's health system expert Vidal Seegobin to unpack the details of the story, interpret General Catalyst's ambition, and share what they'll be watching in the coming months. Links: Radio Advisory's financial impact playlist Survey insights: 6 priorities for health system strategists in 2024 Ep. 193: Is health system growth still possible? Ep. 123: Is private equity health care's bad guy? The Hospital Benchmark Generator Improving detection of ATTR-CM: Insights from experts A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
Artificial intelligence has been rocking industries across the world, and healthcare is no exception. But what impact will it have exactly on physicians? Health systems? Data sovereignty? In this episode, host Rachel (Rae) Woods passes the microphone to Eric Larsen, President Emeritus of Advisory Board and President of TowerBrook Advisors. In this conversation, Eric sits down with Dr. John Halamka, President of the Mayo Clinic Platform, to demystify how the industry should think about generative AI across all of healthcare. Links: Ep. 185: AI adoption: why you can't afford to "wait and see" Ep. 180: Tom Lawry on why AI has a PR problem Lessons from the C-suite AI in healthcare: Insights from 10 C-suite executives Learn more about Advisory Board Sponsorship Learn more about Advisory Board's 2024 Revolutions in Specialty Care Summit A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
Headlines about the future of surgery often focus on robots in the operating room– but innovation in surgical care and operations goes beyond robotics. In reality, the solutions to surgery leaders' problems – like inefficiency and dwindling margins – may be less futuristic than you'd think. In this episode, host Rachel (Rae) Woods invites Advisory Board experts Isis Monteiro, Miles Cottier, and Paul Trigonoplos to discuss what is next for the future of surgery, and what it will actually take for health systems to make surgical care profitable again. They discuss innovations in the OR, opportunities to improve efficiency, and why it might be time to think differently about the future of surgery. Links: Mentioned in the interview (15:00): Open source code that optimizes operating room efficiency Ep. 142: The dire state of hospital finances (Part 1: Hospital of the Future series) Ep. 193: Is health system growth still possible? General surgery service line outlook – 2023 [Webinar on Feb. 27] How health systems are preparing for the future of surgery Use the Market Scenario Planner tool Learn more about Advisory Board's 2024 Revolutions in Specialty Care Summit A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
The data doesn't lie: site-of-care shifts are accelerating. Health systems rely on surgical volumes as a major revenue driver, but as more procedures take place outside of the hospital, systems are not necessarily positioned to capture the shift in volumes – or revenues. So, what should health systems do? To answer that question, host Abby Burns talks with Advisory Board experts Nick Hula and Sebastian Beckmann. They discuss why health systems need to transition from a "defensive" to "offensive" approach to capture shifting volumes and identify service- and market-level factors systems should consider when putting this mindset shift into action. Links: Site-of-care shifts: The next savings opportunity for health plans? Ep. 193: Is health system growth still possible? 5 trends (re)shaping site-of-care shifts What's happening with joint replacement volumes? Learn more about Advisory Board's on-demand courses Learn more about the Advisory Board Fellowship at: advisory.com/fellowship A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
We've all seen headlines about decreasing quality in U.S. healthcare. In an industry battling with workforce shortages, rising health needs, missed prevention, workplace violence, and rising healthcare needs, it's no wonder quality is falling and adverse events are rising. The fact is: in 2024, the patients are not all right. In this episode, host Rachel (Rae) Woods talks with Advisory Board equity expert Darby Sullivan about the state of clinical quality. Following that, we hear from Dr. David Baker, Executive Vice President for Healthcare Quality Evaluation and Improvement at The Joint Commission, to discuss why patient quality is declining and what the industry can do to improve it. In the conversation, they discuss how we define and measure clinical quality, what leaders can do to improve outcomes, and more. Links: The Joint Commission How to tackle the 4 root causes of stagnating clinical quality 4 ways to 'fire-proof' your quality efforts Is clinical quality declining? A look at the data — and what you can do. Learn more about Advisory Board's on-demand courses How UPMC improved interdisciplinary care for metastatic breast cancer and geriatric patients A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
Between high labor costs, inflation, workforce shortages, and a host of other challenges, the past couple of years have been some of the most straining financial times for health systems in recent memory. Though the tides may be starting to turn, it is critical that health systems do not get complacent. How can health systems prepare to grow in the midst of an optimistic yet volatile landscape? Paradoxically, the growth path for health systems is actually to shrink. That’s why, in this episode, host Rachel (Rae) Woods invites Advisory Board health systems expert Vidal Seegobin, and quantitative insights expert Larry Watts to discuss why heath systems might have to first shrink in order to grow and prepare themselves for the future. Throughout the conversation, they discuss why leaders need to look past the optimism of short term relief, and why hospital-based health systems need to start working smarter and not harder. Links: [Tool] Market Scenario Planner Ep. 147: Pursuing growth in today's financial landscape [Rerun] The dire state of hospital finances (Part 1: Hospital of the Future series) Survey insights: 6 priorities for health system strategists in 2024 Ep. 161: Unwavering purpose, the creation of Ballad Health 3 reasons to prioritize comprehensive sleep services Need a quick answer to a healthcare question? Ask Advisory! Whether it's about where the market is headed, or how to navigate our website our team of experts are just a call or email away. Visit ask.advisory.com or email ask@advisory.com to learn more. A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
Last week, in the first part of our series on what CEOs need to pay attention to in 2024, we discussed several of the seismic changes that have emerged in the healthcare industry. In particular, we discussed where care is delivered, and how the healthcare industry is shifting from hospital-first care delivery to vertically integrated ecosystems. In part two of our series, host Rachel (Rae) Woods welcomes back Advisory Board experts Natalie Trebes, Prianca Pai, and Sharon Yuen to discuss two other seismic shifts: who delivers care and how it’s paid for. In the conversation, they discuss how care team roles are shifting in a world of generative AI, how treatment economics are evolving in the new era of bespoke care, and more. Links: Ep. 191: What CEOs need to know in 2024 (Part 1) Bold predictions for healthcare in 2024 Ep. 189: A preview of Advisory Board's 2024 research 11 Things CEOs Need to Know in 2024 Improving detection of ATTR-CM: Insights from experts Learn about Advisory Board Sponsorship at advisory.com/sponsorship A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
As we step into 2024, there is no denying that the healthcare industry is vastly different than it was 5 years ago, 1 year ago, maybe even one month ago. As the immediacy of the pandemic has ebbed, several other seismic changes have emerged that promise to transform the core of the healthcare industry. Understandably, healthcare leaders are concerned about the pressures they face today and those that lie ahead in 2024. That's why, in part 1 of a two-part series on what CEOs need to know in 2024, host Rachel (Rae) Woods invites Advisory Board experts Natalie Trebes, Prianca Pai, and Sharon Yuen to unpack these seismic changes and discuss how leaders should be preparing for the future. Links: Bold predictions for healthcare in 2024 11 Things CEOs Need to Know in 2024 Ep. 189: A preview of Advisory Board's 2024 research Ep. 145: Part 1: What CEOs need to know in 2023 Learn about Advisory Board Sponsorship at advisory.com/sponsorship Advisory Board On-Demand Courses A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
Every year, Advisory Board receives thousands of questions from healthcare leaders about what's happening in the industry and how their organizations should respond. The team who answers these questions is called AskAdvisory – and today we're giving listeners a behind-the-scenes look at how these experts help leaders answer their most pressing questions. In Part 1 of this episode, host Rachel (Rae) Woods invites some of our AskAdvisory colleagues to answer some of the questions they've received this year. Then, in Part 2, Rae invites Chris Phelps, lead producer of the Radio Advisory team, to give listeners an inside look on how we make Radio Advisory. Links: The board’s guide to 5 AI challenges The Hospital Benchmark Generator Low-acuity fast track Market Scenario Planner National site-of-care shift maps Ep. 159: Ozempic, Wegovy, and our questions on weight management drugs Ep. 172: Build a value-based enterprise: Live from 2023 Value-Based Care Summit Ep. 145: Part 1: What CEOs need to know in 2023 Ep. 146: Part 2: What CEOs need to know in 2023 Encore: Revisiting our conversation on building ethical AI systems Ep. 173: 4 ways to prevent a physician shortage [Bonus content] Follow Advisory Board on Instagram A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
With the new year just around the corner, we wanted to take some time to reflect on everything we've researched in the last twelve months and set our research agenda for the year ahead. In 2023, we spent a lot of time focusing on how to overcome a difficult financial landscape, what AI means for the future of healthcare, and how the industry should reckon with new high-cost drugs. But what will we be focusing on in 2024? In this episode, guest host Rachel (Rae) Woods invites eleven (yes, you read that right) Advisory Board experts to discuss what exactly is on our radar in the new year and what you can expect to hear from us here at Radio Advisory throughout 2024. Topics include: (1:23) Strengthening care teams (4:20) Generative AI (6:44) Payer-provider partnerships (10:02) Future of hospital sustainability (11:57) Future of cancer care (14:51) Financing and integrating innovation (17:37) Ambulatory surgery center strategy (20:19) Value-based care performance Links: Ep. 144: What's on our radar for 2023 The best AI strategy isn't about AI How technology can help solve the workforce crisis 6 insights on the medical group landscape for 2024 [Webinar, Jan. 11, 2024] The future of cancer care — and how to prepare 4 essential EOY conversations to have with your nursing team 3 takeaways from our latest webinar on AI in healthcare A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
Women experience healthcare differently compared to men – women consistently have worse outcomes when it comes to chronic diseases, feel unheard, and are oftentimes left out of education and research. Women's health also gets conflated with maternal health, but we know women's health is so much bigger than pregnancy. Improving women's health outcomes requires a more holistic approach to caring for women, but allocating more dollars when working with limited resources may feel unsustainable to some organizations. In this episode, host Rachel (Rae) Woods invites Advisory Board's Gaby Marmolejos, Kara Marlatt, and Ellie Wiles to discuss why there's a strong business case to better meet women's needs, including but not limited to maternal health. Links: 6 things to understand about women's health in the United States 5 steps to improve women's health and well-being How to Grow Share of Wallet with Women's Primary Care Ep. 175: We need to talk about maternal health in America [Bonus content] [Infographic] How healthy is your structural heart program? A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
It's no secret that the US is in the midst of a behavioral health crisis—and with the impacts of unmet need affecting every corner of the industry, many leaders are feeling powerless to sustainably address it. In this episode, guest host Abby Burns invites ChristianaCare's Chief Biopsychosocial Officer, Erin Booker, to discuss how Erin is driving—and making the case for—a comprehensive and holistic behavioral health care strategy. Erin shares how she converted her CFO to be a champion for integrated behavioral health care, as well as how she approaches workforce challenges, partnership, and policy advancement. Links: ChristianaCare's website Ep. 154: The behavioral health crisis won't change (unless we do) The 5 root causes of behavioral health inequity Ep. 68: Seattle Children's approach to behavioral health Tactics to build a stronger behavioral health system Learn more about Advisory Board's on-demand courses A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
In the past few months, we have talked a lot about high-cost drugs. We've done episodes on new innovations, equity implications, the rise of weight management drugs and more. While there is a lot to be excited about, there is a lot to be anxious about too, like high costs and impending legislation. A lot of the industry is tempted to "wait and see" what the new era of drugs will bring, but the reality is that "new era" is already here. That's why, in this episode, host Rachel (Rae) Woods invites Advisory Board pharmacy experts Rachael Peroutky and Chloe Bakst to discuss how the industry should be thinking about this new era of drugs, and why healthcare organizations can't afford to sit around today and strategize later. Links: Ep. 177: Advancing equity in a world of innovation for some, costs for all: Live from the 2023 Clinical Innovation Summit Ep. 167: How nervous should we be about high-cost drugs? Ep. 159: Ozempic, Wegovy, and our questions on weight management drugs [Webinar Recording] State of the Industry: How high-cost drugs change everything Read Advisory Board's case study about how University of Michigan Health-West improved clinician well-being with Nuance's Dragon Ambient eXperience (DAX). A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
It is no question that we are in an unprecedented era of technological change. Large language models and the rise of generative AI have dominated industry conversations in recent months, and for good reasons. It's clear that AI is here to stay, but what isn't so clear is how the industry should adopt it. Should you run headfirst into experimentation? Or wait for data and case studies before implementation? In this episode, host Rachel (Rae) Woods invites Advisory Board digital health experts Ty Aderhold and Elysia Culver to discuss how the industry needs to be thinking about AI adoption and integration. Throughout the conversation, they discuss what we can (and cannot) learn from past technologies, what it means to be an "early mover" or "fast follower," and why taking an incremental approach can empower your business strategy. Have a healthcare question? Want to learn more about what goes on behind-the-scenes at Radio Advisory? Submit your question and we may use it in our final episode of 2024! Email podcasts@advisory.com or leave us a voice message by Thanksgiving for consideration. Thanks! Links: The best AI strategy isn't about AI Overcoming AI challenges to unlock potential Leading the way: How health system executives approach AI in healthcare Ep. 180: Tom Lawry on why AI has a PR problem Ep. 138: Microsoft's head of AI on building ethical systems Visit advisory.com/AIstrategy to learn what's necessary for AI to drive transformative outcomes in the healthcare landscape. A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
During the COVID-19 Public Health Emergency, the federal government and insurers implemented several measures to expand coverage options and better ensure ease of access to healthcare services. One of the most significant policies was the expansion of Medicaid programs and the requirement that individuals be continuously enrolled through the end of the PHE. The expanded eligibility ended when the PHE expired in May 2023, and the industry is reeling from the whiplash of coverage changes. In this episode, host Rachel (Rae) Woods invites Advisory Board health plan experts Chelsea Needham and Sally Kim to discuss what you need to know about Medicaid redeterminations, how health plans are responding, and what this means for the healthcare industry. Have a healthcare question? Want to learn more about what goes on behind-the-scenes at Radio Advisory? Submit your question and we may use it in our final episode of 2024! Email podcasts@advisory.com or leave us a voice message by Thanksgiving for consideration. Thanks! Links: A deep dive into the end of the COVID PHE A 'staggering' 15M+ Americans could lose Medicaid coverage Why are 600+ rural hospitals at risk of closing? C-Suite Cheat Sheet: Medicaid Expansion Visit advisory.com/expertsupport to learn how you can bring Advisory Board experts to your organization to deliver presentations, workshops, and more on AI and other topics that keep healthcare leaders up at night. A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
loading
Comments (2)

muhammad aaman

Thor Sound Booster

Jan 18th
Reply

Samad Navesi

sogood voice the better peace world..♥️🎉🧿

Jan 16th
Reply
Download from Google Play
Download from App Store